Matches in DBpedia 2016-04 for { ?s ?p "Bupropion/zonisamide (planned trade name Empatic) is an experimental drug combination for the treatment of obesity.It is being developed by Orexigen Therapeutics. It is currently at phase II testing. The combination consists of two prescription medications approved by the U.S. Food and Drug Administration (FDA) for other ailments. When mixed together and tested along with proper diet and moderate exercise, they produced a substantial weight loss effect higher than the group taking a placebo."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- zonisamide comment "Bupropion/zonisamide (planned trade name Empatic) is an experimental drug combination for the treatment of obesity.It is being developed by Orexigen Therapeutics. It is currently at phase II testing. The combination consists of two prescription medications approved by the U.S. Food and Drug Administration (FDA) for other ailments. When mixed together and tested along with proper diet and moderate exercise, they produced a substantial weight loss effect higher than the group taking a placebo.".
- Q4998035 comment "Bupropion/zonisamide (planned trade name Empatic) is an experimental drug combination for the treatment of obesity.It is being developed by Orexigen Therapeutics. It is currently at phase II testing. The combination consists of two prescription medications approved by the U.S. Food and Drug Administration (FDA) for other ailments. When mixed together and tested along with proper diet and moderate exercise, they produced a substantial weight loss effect higher than the group taking a placebo.".